Sabuwar gwajin yau da kullun don Autism

Quadrant Biosciences Inc. ya sanar a yau cewa Ofishin Jakadancin Amurka (USPTO) ya ba da kamfanin da abokansa, SUNY Research Foundation da Penn State Research Foundation, US Patent No. 11,242,563 (Analysis of Autism Spectrum Disorder). Tabbacin ya ƙunshi harsashin kimiyya don haɓaka tushen saliva, taimakon bincike na Autism multiomic, wanda zai iya bambanta daidaikun mutane masu Autism daga daidaikun mutane masu ci gaba na yau da kullun ko jinkirin ci gaba ta hanyar auna matakan microRNA (miRNA) da microbiome a cikin miya. Quadrant Biosciences, wani kamfani na Kimiyyar Rayuwa da ke Syracuse, New York, yana ba da damar tsara tsararraki na gaba da AI don haɓaka ƙididdigar ƙwayoyin ƙwayoyin cuta na RNA don kewayon yanayin kiwon lafiya.   

"Bayar da takardar shaidar mallakar Amurka na hukuma don aikinmu kan haɓaka agajin bincike na tushen salwa ga Autism tabbataccen yarda ne na sabon abu da amfani da tsarin da muka ɓullo da," in ji Frank Middleton, PhD, Farfesa a SUNY Upstate Medical Jami'a kuma ɗaya daga cikin manyan masu bincike a bayan binciken haƙƙin mallaka. "Mayar da hankali kan ƙaddamar da tsarin multiomic wanda ya haɗu da fasalin RNA na tsari daga mai masaukin ɗan adam da kuma microbiome na baka ya ba da haske mai yawa game da cutar ta Autism."

Dokta Steve Hicks, MD, PhD daga Kwalejin Medicine na Jihar Penn, sauran mahimmin mai ƙirƙira kan haƙƙin mallaka, ya bayyana yuwuwar tasirinsa na asibiti. "Muna fatan wannan kayan aiki na kwayoyin zai inganta ikon likitocin don bambance yara a kan nau'in autism daga takwarorinsu tare da jinkirin ci gaban da ba autistic ba, yana ba da damar ganowa a baya da kuma farawa da farko na maganin halayya. Haka kuma," ya ci gaba da cewa, "wannan muhimmin ci gaba yana tabbatar da ingantaccen sabon abu a cikin binciken Quadrant Biosciences' kuma yana haɓaka burin mu na inganta kula da lafiya ga yara masu fama da cutar Autism."

Rich Uhlig, wanda ya kafa kuma Shugaba na Quadrant Biosciences ya ce "Mun yi farin ciki da cewa USPTO ta ba da izinin mu don wannan aikin mai ban sha'awa." "Wannan yana goyan bayan ƙoƙarce-ƙoƙarcen R&D na shekarunmu don haskaka abubuwan epigenetic da ke da alaƙa da Autism, da haɓaka sabbin masu gano ƙwayoyin cuta don magance buƙatar gaggawa na rage tsawaita yanayin gano cutar Autism ga iyaye da masu kulawa."